FDA relaxes oversight of general wellness devices, CDS software

Regulatory NewsRegulatory NewsArtificial intelligence/machine learning (AI/ML)Diagnostics/IVDsDigital health/SaMD/AIGuidanceMedical DevicesRegulatory Intelligence/PolicyUnited StatesUS Food and Drug Administration (FDA)